CYTOMETRY PART B-CLINICAL CYTOMETRY
metrics 2024
Fostering interdisciplinary collaborations in clinical cytometry.
Introduction
CYTOMETRY PART B-CLINICAL CYTOMETRY, published by Wiley, is a premier journal dedicated to advancing the field of cytometry with a specific focus on its clinical applications. With an impact factor reflective of its influential role in the scientific community, this journal serves as an essential resource for researchers, professionals, and students keen on exploring the latest developments in pathology, histology, and cell biology. The journal holds impressive rankings—Q1 in Pathology and Forensic Medicine and Q2 in Histology—illustrating its critical standing within the academic landscape. Covering a wide array of topics from clinical techniques to innovative applications in cytometry, it aims to disseminate high-quality research findings that contribute to enhanced diagnostic and therapeutic strategies. As an Open Access journal, it ensures that its valuable content reaches a broader audience, facilitating knowledge-sharing and fostering collaborations across interdisciplinary fields. Since its inception in 2002, CYTOMETRY PART B continues to shape the future of clinical cytometry, making significant contributions to both academia and clinical practice.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
Journal of Cytology
Unlocking the Mysteries of Cells: A Journal for the Curious Mind.Journal of Cytology, published by Wolters Kluwer Medknow Publications, stands as a pivotal resource in the fields of cytology, histology, and pathology. With an ISSN of 0970-9371 and an E-ISSN of 0974-5165, this peer-reviewed, open-access journal has been disseminating vital research since its inception in 1985, transitioning to open access in 2008 to enhance global accessibility to its scholarly articles. Operating from its base in Mumbai, India, the journal is categorized in the Q3 quartile for histology and pathology according to the 2023 rankings, affirming its ongoing contribution to the scientific community. Researchers and professionals can benefit from a wide array of cutting-edge studies and reviews that advance the understanding of cytological practices. The journal's commitment to disseminating high-impact research is reflected in its Scopus rankings, positioning it among the significant players in its field. By facilitating open access, the Journal of Cytology aims to foster knowledge exchange and inspire new investigations among scholars, clinicians, and students alike.
JOURNAL OF CLINICAL PATHOLOGY
Connecting Evidence to Effective TreatmentJOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.
Diagnostics
Championing Open Access for Diagnostic InnovationDiagnostics is a pioneering open-access journal published by MDPI, catering to the critical field of clinical biochemistry since its establishment in 2011. Based in Switzerland, this esteemed journal, with E-ISSN 2075-4418, has gained significant recognition within the academic community, reflected in its 2023 Scopus rankings placing it in Q2 for Clinical Biochemistry and showcasing its impact in related medical disciplines. With a commitment to disseminating high-quality research that advances the understanding of diagnostic techniques and methodologies, Diagnostics covers a broad spectrum of topics including biochemical markers, diagnostic imaging, and molecular diagnostics. The journal's open access model ensures that groundbreaking findings are readily available to researchers, professionals, and students alike, fostering an environment of knowledge sharing and collaboration. As the field of diagnostics continues to evolve, Diagnostics remains at the forefront, paving the way for innovations that enhance health outcomes globally.
JOURNAL OF MAGNETIC RESONANCE IMAGING
Catalyzing Progress in Radiology and Nuclear Medicine.JOURNAL OF MAGNETIC RESONANCE IMAGING (ISSN: 1053-1807; E-ISSN: 1522-2586), published by WILEY, stands as a leading academic platform in the field of Radiology, Nuclear Medicine, and Imaging. With an impressive impact factor that reflects its Q1 ranking in the respective category and a notable Scopus rank of 30 out of 333 journals, this journal serves as a critical resource for cutting-edge research and innovative practices in magnetic resonance imaging. Since its inception in 1991, it has provided a repository of high-quality research, reviews, and clinical applications aimed at enhancing the understanding and technological advancements within the imaging community. Although it does not offer Open Access, the journal's comprehensive approach ensures that professionals, researchers, and students alike can gain crucial insights and contribute significantly to the evolving landscape of medical imaging. With a commitment to excellence and relevance, the journal continues to push the boundaries of knowledge and practice in its field.
CYTOMETRY PART A
Advancing the Frontiers of Cell AnalysisCYTOMETRY PART A, published by WILEY, stands as a premier journal within the fields of Cell Biology, Histology, and Pathology and Forensic Medicine. With an impressive impact factor reflected in its prestigious 2023 quartile rankings—Q2 in Cell Biology and Q1 in both Histology and Pathology and Forensic Medicine—this journal is recognized for its influential contributions to advancing the understanding of cytometry in clinical and research settings. The journal, which spans research from 2003 to 2024, is dedicated to publishing high-quality studies, comprehensive reviews, and innovative methodologies that drive the field forward. As part of its commitment to accessibility, CYTOMETRY PART A provides open access options, ensuring that vital research findings are readily available to the scientific community and beyond. Researchers, professionals, and students alike are invited to explore the vast array of articles that not only elucidate the complexities of cellular systems but also enhance diagnostic techniques and therapeutic strategies.
CLINICAL NUCLEAR MEDICINE
Connecting Global Researchers for a Healthier TomorrowCLINICAL NUCLEAR MEDICINE is a premier journal dedicated to the field of nuclear medicine, published by Lippincott Williams & Wilkins. With a history of excellence since its inception in 1978, the journal serves as a vital resource for researchers, healthcare professionals, and students seeking to deepen their understanding of this rapidly evolving discipline. The journal holds a commendable Q2 ranking in both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging, reflecting its significant impact on advancing clinical practices and research. While currently not offered as an open-access publication, CLINICAL NUCLEAR MEDICINE ensures rigorous peer review and high-quality publications, contributing to the broad dissemination of cutting-edge studies and reviews. With its comprehensive scope encompassing both diagnostic and therapeutic nuclear medicine applications, researchers around the globe turn to this journal to stay informed and inspire innovations in patient care for the years leading up to 2024 and beyond.
Clinical Pathology
Empowering Pathology Through Innovative ResearchClinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.
DIAGNOSTIC CYTOPATHOLOGY
Unveiling Insights in Cytopathology for Better HealthDIAGNOSTIC CYTOPATHOLOGY is a scholarly journal dedicated to advancing the field of cytopathology through the publication of high-quality research and reviews. Founded in 1985 and published by Wiley, this journal provides vital insights into the diagnosis and management of diseases through cytological techniques. With a strong presence in the academic community, it currently holds a Q3 ranking in the fields of Histology, Medicine (miscellaneous), and Pathology and Forensic Medicine, reflecting its commitment to fostering knowledge and innovation in these areas. Researchers and clinicians alike can benefit from its comprehensive articles that delve into cutting-edge methodologies and diagnostic strategies. Although not an Open Access journal, DIAGNOSTIC CYTOPATHOLOGY remains a crucial resource for professionals seeking to enhance their understanding and practice in the diagnostic realm. With an ISSN of 8755-1039 and an E-ISSN of 1097-0339, the journal continues to publish impactful studies well into 2024, ensuring that essential advancements in cytopathology reach a global audience.
Quantitative Imaging in Medicine and Surgery
Advancing Imaging Science for Better Patient OutcomesQuantitative Imaging in Medicine and Surgery is an esteemed journal dedicated to advancing the field of medical imaging through rigorous research and innovative methodologies. Published by AME PUBLISHING COMPANY in China, this journal has established itself with an impressive Q2 quartile ranking in the field of Radiology, Nuclear Medicine, and Imaging, reflecting its dedication to high-quality research. With a comprehensive focus on quantitative imaging techniques, the journal covers a wide range of topics including image analysis, imaging biomarkers, and the integration of imaging in clinical practice, promoting collaboration between imaging specialists and clinicians. As an open access journal, Quantitative Imaging in Medicine and Surgery ensures that its articles are freely accessible, facilitating the dissemination of knowledge to a broader audience. With a commitment to fostering innovation in imaging science, this journal serves as an invaluable resource for researchers, professionals, and students alike, ultimately aiming to improve patient outcomes through advanced imaging strategies and technologies.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY
Connecting researchers and clinicians for better outcomes.OTOLARYNGOLOGY-HEAD AND NECK SURGERY, published by Wiley, stands as a premier journal in the fields of otorhinolaryngology and surgery, boasting an impressive impact ranking in the 95th percentile among its peers. With an ISSN of 0194-5998 and E-ISSN 1097-6817, this journal has been a cornerstone for researchers and clinicians since its inception in 1978, continuing its valuable contributions to 2024. Notably, it holds a Q1 category ranking in both Otorhinolaryngology and Surgery, exemplifying its influence and the high caliber of research it publishes. As it garners significant attention in the scientific community, researchers are encouraged to delve into its articles for comprehensive insights into advanced surgical techniques and emerging trends in head and neck medicine. Access to its extensive repository of research is available through traditional subscription models, allowing professionals and students alike to benefit from the wealth of knowledge at their fingertips.